GlassScriptPhysician profile
Priscella S Chan
NPI 1437788346
$1,364.11
in general payments reported to CMS, 2019-2025
19 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $51.48 · 2024: $200 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $697.22 | 2025 | Rezdiffra |
| Sanofi-Aventis U.S. LLC | $98.75 | 2025 | |
| Merck Sharp & Dohme LLC | $71.50 | 2023-2025 | Verquvo, Capvaxive, Vaxelis |
| Paratek Pharmaceuticals, INC. | $68.52 | 2024-2025 | Nuzyra |
| Alk-Abello, INC | $47.50 | 2025 | Odactra, Grastek, Ragwitek |
| Abbvie INC. | $42.45 | 2024-2025 | |
| Pfizer INC. | $39.66 | 2024 | |
| Glaxosmithkline, LLC. | $33.52 | 2024 | Bexsero |
| Vertex Pharmaceuticals Incorporated | $32.36 | 2025 | |
| Sumitomo Pharma America, INC. | $32.21 | 2025 | Gemtesa |
| Lexicon Pharmaceuticals, INC. | $29.30 | 2024 | |
| Hologic Sales and Service, LLC | $25.23 | 2025 | Aptima, Thinprep 2000 Processor |
| Cipher Pharmaceuticals US LLC | $24.51 | 2025 | Natroba, Spinosad |
| Sanofi Pasteur INC. | $23.52 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.36 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $23.29 | 2025 | Rexulti |
| Genzyme Corporation | $21.60 | 2025 | |
| Lilly USA, LLC | $15.30 | 2024 | Jardiance |
| Esperion Therapeutics, INC. | $14.31 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscella Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.